Volume 1, Issue 1 (August 2022)
Health Science Monitor 2022, 1(1): 24-31 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khatami S H, Movahedpour A, Taheri-Anganeh M. Serological and RT-PCR diagnosis approaches for COVID-19. Health Science Monitor 2022; 1 (1) :24-31
URL: http://hsm.umsu.ac.ir/article-1-52-en.html
URL: http://hsm.umsu.ac.ir/article-1-52-en.html
Cellular and Molecular Research Center, Research Institute on Cellular and Molecular Medicine, Urmia University of Medical Sciences, Urmia, Iran
Abstract: (833 Views)
The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, caused COVID-19, is a pandemic disease and recently become dangerous to humans in all over the world. There is no efficient medicine for treatment of infected patients, and thousands of people are dying. Real Time-Polymerase Chain Reaction (RT-PCR) is a gold standard assay for COVID-19 diagnosis. Currently, RT-PCR assay is the routine method for detecting COVID-19, and several specific primers for different genes of SARS-CoV-2 are used. However, RT-PCR is not a perfect test, and its reliability depends on the sampling quality and accuracy of the equipment. Mutation occurrence in the virus genome and impurity in extracted RNA samples of the virus might lead to false results. Many efforts are carried out to detect SARS-CoV-2 according to various serological methods such as Enzyme-Linked Immunosorbent Assay (ELISA), colloidal gold-based, and chemiluminescence assays. Finally, the combination of molecular methods like RT-PCR and serological assays such as ELISA can improve the validity and reliability of aforementioned tests. Here, we summarize the results of some molecular and serologic tests for SARS-CoV-2 detection.
Type of Study: Applicable |
Subject:
General
Received: 2022/08/1 | Accepted: 2022/08/23 | Published: 2022/08/20
Received: 2022/08/1 | Accepted: 2022/08/23 | Published: 2022/08/20
References
1. Vakili S, Savardashtaki A, Jamalnia S, Tabrizi R, Nematollahi MH, Jafarinia M, et al. Laboratory Findings of COVID-19 Infection are Conflicting in Different Age Groups and Pregnant Women: A Literature Review. Archives of Medical Research. 2020. [DOI]
2. Bustin SA, Nolan T. RT-qPCR Testing of SARS-CoV-2: A Primer. International Journal of Molecular Sciences. 2020;21(8):3004. [DOI] [PMID] [PMCID]
3. Organization WH. Laboratory testing for coronavirus disease ( COVID-19) in suspected human cases: interim guidance, 19 March 2020. World Health Organization; 2020. [Google Scholar]
4. Organization WH. Laboratory biosafety guidance related to coronavirus disease ( COVID-19): interim guidance, 13 May 2020. World Health Organization; 2020. [URL]
5. Carter LJ, Garner LV, Smoot JW, Li Y, Zhou Q, Saveson CJ, et al. Assay Techniques and Test Development for COVID-19 Diagnosis. ACS central science. 2020;6(5):591-605. [DOI] [PMID] [PMCID]
6. Carter LJ, Garner LV, Smoot JW, Li Y, Zhou Q, Saveson CJ, et al. Assay Techniques and Test Development for COVID-19 Diagnosis. ACS Publications; 2020. [DOI] [PMID] [PMCID]
7. Wikramaratna P, Paton RS, Ghafari M, Lourenco J. Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR. medRxiv. 2020:2020.04.05.20053355. [DOI] [PMID] [PMCID]
8. Maurer JJ. Rapid Detection and Limitations of Molecular Techniques. Annual Review of Food Science and Technology. 2011;2(1):259-79. [DOI] [PMID]
9. Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert review of molecular diagnostics. 2020;20(5):453-4. [DOI] [PMID] [PMCID]
10. Maggi RG, Birkenheuer AJ, Hegarty BC, Bradley JM, Levy MG, Breitschwerdt EB. Comparison of serological and molecular panels for diagnosis of vector-borne diseases in dogs. Parasites & Vectors. 2014;7(1):127. [DOI] [PMID] [PMCID]
11. Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clinical Infectious Diseases. 2020. [DOI]
12. Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clinical Infectious Diseases. 2020. [DOI] [PMID] [PMCID]
13. Okba NM, Muller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, et al. SARS-CoV-2 specific antibody responses in COVID-19 patients. medRxiv. 2020. [DOI]
14. Lou B, Li T, Zheng S. Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset. medRxiv. Preprint posted March. 2020;27. [DOI] [PMID] [PMCID]
15. Fernández-Carballo BL, McBeth C, McGuiness I, Kalashnikov M, Baum C, Borrós S, et al. Continuous-flow, microfluidic, qRT-PCR system for RNA virus detection. Analytical and bioanalytical chemistry. 2018;410(1):33-43. [DOI] [PMID]
16. Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, et al. Diagnostic testing for severe acute respiratory syndrome-related coronavirus-2: A narrative review. Annals of internal medicine. 2020. [DOI] [PMID] [PMCID]
17. Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, Kim SY, et al. Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020;40(5):351-60. [DOI] [PMID] [PMCID]
18. Cai X, Chen J, Hu J, Long Q, Deng H, Fan K, et al. A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Corona Virus Disease 2019 (COVID-19). medRxiv. 2020:2020.02.22.20026617. [DOI]
19. Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Taylor & Francis; 2020. [DOI] [PMID] [PMCID]
20. Pan Y, Li X, Yang G, Fan J, Tang Y, Zhao J, et al. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients. Journal of Infection. 2020. [DOI]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
